CLINICAL_TRIALS
trial_result
· 2014-04-10
Clinical Trial Update: Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia [Phase 2]
Summary
Phase 2 study evaluating the safety and effectiveness of bimatoprost for androgenetic alopecia in men has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Alopecia, Alopecia, Androgenetic | Phase 2 | Status: COMPLETED | Results posted: 2014-04-10